Cardiovascular Risk Factors in Bulgarian Patients with Polycystic Ovary Syndrome and/or Obesity

Table 6

Comparison between the data about clinical hyperandrogenism between the three groups.

	Group 1		Group 2		Group 3
	Obese		Lean PCOS		Obese PCOS
	n		n		n
Clinical hyperandrogenism	60	53.3%^∧∧	83	77.1%^∗∗∗	72	86.1%
Hirsutism	60	51.7%^∧	82	72.0%^∗∗∗	72	84.7%
Increased hair growth on the upper lip	48	31.2%^∧	67	53.7%^∗∗	55	58.2%
Increased hair growth on the sideburns	46	23.9%^∧	67	47.8%^∗∗	55	58.2%
Increased hair growth on the beard	47	37.6%	67	50.7%^∗∗∗	55	70.9%^#
Increased hair growth on the chest	47	10.6%^∧∧	67	34.3%^∗∗	54	37.0%
Increased hair growth on the abdomen	48	27.1%^∧∧∧	67	62.7%^∗∗	56	60.7%
Increased hair growth on the inner thighs	48	14.6%^∧∧∧	66	50.0%^∗∗∗	55	65.5%
Acne	50	4.0%	70	12.9%	62	1.6%
Androgenic alopecia	50	4.0%	73	6.8%	63	1.6%
Ferriman-Gallwey score	12	7.42±2.47	37	9.16±3.59	15	9.40±4.17

^#𝑃<0.05; between group 1 and group 3.
* 𝑃<0.05; **𝑃<0.01; ***𝑃<0.001 between group 2 and group 3.
^∧𝑃<0.05; ^∧∧𝑃<0.01; ^{∧∧ ∧}𝑃<0.001 between group 1 and group 2.
n = number of patients.